After primary infection , varicella-zoster virus (VZV) becomes latent in ganglia. VZV reactivation occurs primarily in elderly individuals, organ transplant recipients , and patients with cancer and AIDS , correlating with a specific decl ine in cellmediated immunity to VZV. VZV can also reactivate after surgical stress. To determine whether VZV can also reactivate after acute non-su rgical stress , we examined total DNA extracted from 312 saliva samples of eight astronauts before, during and after space flight for VZV DNA by PCR: 112 samples were obtained 234 to 265 days before fl ight, 84 samples on days 2 through 13 of space flight , and 116 samples on days 1 through 15 after flight. Before space flight only one of the 112 saliva samples from a single astronaut was positive for VZV DNA. In contrast, during and after space flight , 61 of 200 (30%) saliva samples were positive in all 8 astronauts . No VZV DNA was detected in any of 88 saliva samples from 10 healthy control subjects. These data indicate that VZV can reactivate subclinically in healthy individuals after acute stress.
Abstract. After primary infection , varicella-zoster virus (VZV) becomes latent in ganglia. VZV reactivation occurs primarily in elderly individuals, organ transplant recipients , and patients with cancer and AIDS , correlating with a specific decl ine in cellmediated immunity to VZV. VZV can also reactivate after surgical stress. To determine whether VZV can also reactivate after acute non-su rgical stress , we examined total DNA extracted from 312 saliva samples of eight astronauts before, during and after space flight for VZV DNA by PCR: 112 samples were obtained 234 to 265 days before fl ight, 84 samples on days 2 through 13 of space flight , and 116 samples on days 1 through 15 after flight. Before space flight only one of the 112 saliva samples from a single astronaut was positive for VZV DNA. In contrast, during and after space flight , 61 of 200 (30%) saliva samples were positive in all 8 astronauts . No VZV DNA was detected in any of 88 saliva samples from 10 healthy control subjects. These data indicate that VZV can reactivate subclinically in healthy individuals after acute stress.
Space flight provides a model of acute , non-surgical stress, involving a unique and unfamiliar environment, together with sudden gravitational changes associated with launch and landing, and the critical requirement for precise actions. In fact , measurable acute stress responses , such as increased urinary cortisol and interleukin-6 levels, have been demonstrated during launch and reentry (Stein and Schluter, 1994) . Here, we describe our analysis of saliva samples from eight astronauts (three missions) before , during and after space flight for evidence of VZV reactivation. The samples were coded for blinded polymerase chain reaction (peR) analysis for VZV DNA in two separate laboratories. We also collected serum samples and compared the anti-VZV IgG titer of astronauts to matched controls .
MATERIALS AND METHODS

Subjects.
Eight astronauts (seven men and one woman) , 37 to 51 years of age (mean , 42 .7 yr) during three space shuttle missions , 10 to 12 days in duration were studied. Before flight , all astronauts were seropositive for VZV. Ten healthy individuals in the same age range served as controls. The study was approved by the Johnson Space Center Institutional Review Board.
Sample Collection. Saliva samples were collected from each astronaut, before , during and after flight , on cotton rolls (Salivette kits , Sarstedt Inc., Newton, NC) , stored in polypropylene vials containing 1.0 ml storage buffer (1 % sodium dodecyl sulfate, 10 mM Tris-HCI , pH 8.0 , 1 mM EDTA) , and coded for blinded PCR analysis as described (Payne et ai. , 1999) . Baseline (preflight) samples were collected on arising every other day for 1 month , beginning approximately 6 months before launch. Daily in-flight saliva samples were collected throughout the mission. Post-flight samples were collected on landing day and then daily for 2 weeks. Control saliva samples were collected every other day for 4 weeks. Blood samples were collected from 10 days before flight and 2 to 3 hours after landing. Two blood samples were collected 22 days apart from five control subjects. Th is collection schedule closely approximated the pre-and post-flight collection schedule during a 12-day flight. Serum was obtained and stored at -70 Q C until processed .
DNA Extraction and peR. Saliva specimens were concentrated with a Microsep 100K filtration unit (Filtron Technology Corporation , Northborough , MA) , and DNA was extracted with nonorganic extraction reagents (Qiagen Inc., Chatsworth , CA). Microcarrier gel (Molecular Research Center, Inc., Cincinnati , OH) was added to facilitate DNA recovery (Boehringer Mannheim , Indianapolis, IN). DNA was dissolved in 50 I-li of nuclease-free water (Amresco , Solon , OH) .
Qualitative nested PCR was performed on a 1/25 (2 1-l1) of the extracted DNA using VZV ORF 63-specific primers (Cohrs et ai. , 1996) . Amplified DNA was resolved on agarose gels, stained with ethid ium bromide and the image was captured digitally. Quantitative real -time PCR was performed in a TaqMan 7700 sequence detector (Perkin Elmer Biosystems) using fluorescence-based simultaneous amplification and product detection. Primers and probes for VZV gene 63 and for glyceraldehyde 6-phosphate dehydrogenase (GAPdH) DNA sequences were as described (Cohrs et ai. , 2000) . Antiviral Antibody Assay. IgG antibody against VZV was determined by enzyme immunoassay (EIA) (Forghan i et ai. , 1986) . Each serum sample was tested at a 1 :200 dilution against viral antigen (VA) , a lysate prepared from VZV-infected human diploid lung cells , and against control antigen (CA) , a lysate prepared from uninfected cells at the same passage level. Data generated by EIA were expressed as optical density index (001) , defined as the absorbance value of VA minus the absorbance value of CA divided by the cut-off (CO) value . CO is defined as the mean absorbance of a large number of VZV-seronegative samples. An 001 of ~1.0 was considered positive for the presence of VZV-specific IgG. An 001 of <1.0 was considered negative for the presence of VZV-specific IgG, and may indicate no prior exposure to the virus.
Statistical Analysis. PCR results were analyzed using logistic regression with random subject effects via SAS Proc NLMIXED (SAS , 1999) to determine outcome significance . Assuming independence and binominal distribution, the probability of detecting VZV DNA was determined by the following formula:
where P ijk is the probability of VZV DNA detection, Li is the detection method (i=1 for nested PCR , i=2 for real-time PCR) , Tj is the effect of the time (j=1 preflight, j=2 for during flight , j=3 for post-flight) , and Sk identifies the ith subject. The (L T)ij terms are detection method by time interactions.
Results
Frequency of VZV DNA detection in saliva before, during and after space flight. Nested PCR analyses was periormed on DNA extracted from 312 saliva samples from eight astronauts. Technique (nested PCR vs . real-time PCR) did not affect the detection of VZV DNA either additively (p = 0.1671) or interactively (p=0.441) . However, the frequency of detection of VZV DNA was significantly greater during and after flight than before flight whether nested PCR (p<0.0098 during and p<0 .0060 after). The copy number of GAPdH DNA did not differ significantly in the saliva samples collected from astronauts before (22 ± 6.3, mean , ±SEM) , during (21 .5±5.9) and after space flight (20.9 ± 4.9) or in control subjects (22.5 ± 4.3) by real-time PCR (ANOVA, p=0.925).
6
Serum anti-VZV IgG in control subjects and astronauts. Serum anti-VZV IgG 001 were determined in five control subjects and in six astronauts 10 days before flight and again 2 to 3 hours after landing. The 001 for one control serum sample was <1 indicating no previous exposure to VZV, and therefore was dropped from the analysis. In the remaining 8 samples from 4 control subjects , the average anti-VZV IgG 001 was 5.8 ± 0.5, as compared with 14.9 ± 1.1 in 12 serum specimens from six astronauts. After accounting for two samples on each subject via analysis of variance , the average anti-VZV IgG 001 for astronauts (14.9 ± 1.1 , k=2 samples on each of n=6 astronauts) was significantly higher (F-test, p=0.01) than the average IgG 001 for controls (5 .8 ± 0.5 , k=2 samples on each of n=4 controls). In each of the six astronauts and 5 controls , there was no significant difference in the anti-VZV IgG titer 10 days before flight compared to that after landing . Unfortunately, serum samples from astronauts weeks to months before or after space flight were not available for analysis .
Discussion
Using a convenient, non-invasive method of detecting amplifiable VZV DNA from human saliva, this study showed an association between VZV reactivation and acute, nonsurgical stress in healthy individuals . Detection of VZV DNA in saliva has been used previously to establish an association between VZV reactivation and facial palsy, Ramsay Hunt syndrome (facial palsy and zoster oticus) and zoster sine herpete (pain without rash) (Furuta et aI. , 2000a; 2000b; . In those disorders, real-time PCR revealed considerable day-to-day variation in VZV DNA copy number, consistent with our find ings in the astronauts examined . In fact , the low conco rdance between our nested PCR and real-time PCR results , based on a correlation coefficient of 0.16 , might reflect sampling variation , low VZV DNA copy number or loss of DNA during storage or shipment. However, PCR results grouped according to time of sampling (before, during and after flight) revealed a high concordance between the two PCR methods.
Of interest, we also found a two to three-fold increase in circulating anti-VZV IgG in astronauts compared to control subjects. Because we were unable to obtain a second serum specimen from astronauts weeks to months after space flight, it was not possible to demonstrate a significant change in antibody to VZV. For example, a four-fold rise and fall in antibody to VZV has been used as evidence of subclinical VZV reactivation in both immunocompromised and immunocompetent individuals (Arvin et aL , 1983; Gershon et aL , 1984; Schunemann et aL , 1998) . However, the combination of VZV DNA in saliva and a higher specific antibody response in serum of the astronauts compared to control subjects further confirms subclinical reactivation of VZV.
Two other human herpesviruses, cytomegalovirus and Epstein-Barr virus, have also been shown to reactivate during and after space flight (Mehta et aL, 2000; Payne et aL , 1999) . Although the mechanism by which herpesviruses reactivate during space fl ight is unknown , the combination of gravitational changes and a confined , unfamiliar environment (extreme isolation from family in a crowded environment, lack of privacy, sleep depravation , micro-gravity, physical and physiological stress) has been associated with increased levels of ACTH and cortisol during and after space flight 2001 b) . Multiple clinical reports also support a role for steroids in zoster. For example , a steroid-dependent asthmatic patient who received two courses of high-dose intravenous methylprednisolone at a time when she was exposed to chickenpox developed classic varicella with complications (Silk et aI. , 1988) . Another study reported four patients who received steroids and developed zoster with an average incubation period of 18 days (Rado et aI. , 1965) . Further, in a study of six zoster patients with preherpetic neuralgia (prolonged pain before rash) , two who had been taking long-term , low-dose steroids developed disseminated skin lesions with neurologic complications of zoster paresis and a fatal zoster encephalitis , respectively (Gilden et aL , 1991) . Finally, steroid therapy in the week before or after VZV vaccination has been associated with an increased incidence of varicella rash (Lydick et aI. , 1989) . While additional experiments are needed to determine how stress-induced hormonal changes lead to human herpesvirus reactivation , this study adds VZV to the list of human herpesviruses that reactivate in response to acute nonsurgical stress. I I I 
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